Results 111 to 120 of about 1,924,275 (351)

Resistance factors in software processes improvement

CLEI Electronic Journal, 2006
Several companies have been carrying out software processes improvement projects. However, some of them give up before the project ends and others take much longer than expected to get it accomplished. This way, identifying the resistance factors that influence the implementation of such projects might serve as a reference to professionals in this area
Abraham Rabelo, Josiane Brietzke
openaire   +4 more sources

An empirical study of maintenance issues within process improvement programmes in the software industry [PDF]

, 2002
Tracy Hall, Austen Rainer, Nathan Baddoo, Sarah Beecham   +3 more
openalex   +1 more source

Peripheral blood proteome biomarkers distinguish immunosuppressive features of cancer progression

Molecular Oncology, EarlyView.
Immune status significantly influences cancer progression. This study used plasma proteomics to analyze benign 67NR and malignant 4T1 breast tumor models at early and late tumor stages. Immune‐related proteins–osteopontin (Spp1), lactotransferrin (Ltf), calreticulin (Calr) and peroxiredoxin 2 (Prdx2)–were associated with systemic myeloid‐derived ...
Yeon Ji Park, Jae Won Oh, Hyewon Chung, Jung Won Kwon, Yi Rang Na, Kwang Pyo Kim, Seung Hyeok Seok   +6 more
wiley   +1 more source

Contribuição dos modelos de qualidade e maturidade na melhoria dos processos de software Contribution of quality and maturity models to software process improvement

Production, 2008
Grande parte das empresas desenvolvedoras de software criou seu próprio processo de trabalho. Devido à rápida expansão do mercado de software, a concorrência ocorre muito mais em custo do que em diferenciação. Para obter vantagem competitiva, as empresas
Antonio Carlos Tonini, Marly Monteiro de Carvalho, Mauro de Mesquita Spinola   +2 more
doaj   +1 more source

Stochastic variation in the FOXM1 transcription program mediates replication stress tolerance

Molecular Oncology, EarlyView.
Cellular heterogeneity is a major cause of drug resistance in cancer. Segeren et al. used single‐cell transcriptomics to investigate gene expression events that correlate with sensitivity to the DNA‐damaging drugs gemcitabine and prexasertib. They show that dampened expression of transcription factor FOXM1 and its target genes protected cells against ...
Hendrika A. Segeren, Kathryn A. Wierenga, Frank M. Riemers, Elsbeth A. van Liere, Bart Westendorp   +4 more
wiley   +1 more source

An integrated framework for simulation‐based Software Process Improvement by Mercedes Ruiz, Isabel Ramos, Miguel Toro, Software Process Improvement and Practice 2004; 9:81–93 [PDF]

, 2005

openalex   +1 more source

CircCCNB1 inhibits vasculogenic mimicry by sequestering NF90 to promote miR‐15b‐5p and miR‐7‐1‐3p processing in nasopharyngeal carcinoma

Molecular Oncology, EarlyView.
CircCCNB1 expression is down‐regulated in nasopharyngeal carcinoma (NPC); thus, less NF90 protein is bound to circCCNB1 and more binds to pri‐miRNAs, blocking their (pri‐miRNAs) binding to DGCR8 and inhibiting the processing and generation of miR‐15b‐5p/miR‐7‐1‐3p. Furthermore, decreased miR‐15b‐5p/miR‐7‐1‐3p promotes the expression of the target genes
Chunmei Fan, Fenghua Tan, Jie Wu, Zhaoyang Zeng, Wenjia Guo, He Huang, Wei Xiong   +6 more
wiley   +1 more source

Organizational Influence Process in Software Process Improvement [PDF]

, 2002
In this paper we investigate organizational influence processes in software process improvement. We analyze an improvement effort through the lenses of organizational influence theory.
Ngwenyama, Ojelanki, Nielsen, Peter Axel
core   +1 more source

SOFTWARE PROCESS DYNAMICS: MODELING, SIMULATION AND IMPROVEMENT [PDF]

, 2006
Mercedes Ruiz, Isabel Ramos, Miguel Toro
openalex   +1 more source

TOMM20 as a driver of cancer aggressiveness via oxidative phosphorylation, maintenance of a reduced state, and resistance to apoptosis

Molecular Oncology, EarlyView.
TOMM20 increases cancer aggressiveness by maintaining a reduced state with increased NADH and NADPH levels, oxidative phosphorylation (OXPHOS), and apoptosis resistance while reducing reactive oxygen species (ROS) levels. Conversely, CRISPR‐Cas9 knockdown of TOMM20 alters these cancer‐aggressive traits.
Ranakul Islam, Megan E. Roche, Zhao Lin, Diana Whitaker‐Menezes, Victor Diaz‐Barros, Eurico Serrano, Maria Paula Martinez Cantarin, Nancy J. Philp, Atrayee Basu Mallick, Ubaldo Martinez‐Outschoorn   +9 more
wiley   +1 more source